Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
LumiraDx Announces the Intended Use for its FDA EUA Authorized High Sensitivity COVID-19 Antigen Test has been Expanded to Include Testing of Asymptomatic Individuals
Today, LumiraDx (Nasdaq: LMDX) a next-generation point of care (POC) diagnostics company announced that the intended use for its Food […]
Mogrify Appoints Tom Graney as Non-Executive Director, Audit Chair and Capital Markets Advisor
Mogrify Limited (Mogrify®), a biopharmaceutical company pioneering the development of a new class of in […]
Dunad Therapeutics Enters Strategic Collaboration with Novartis to Develop Next-generation Oral Targeted Protein Degrader Therapies
Dunad Therapeutics (“Dunad”), a biopharmaceutical company focusing on the development of next-generation targeted protein degradation […]
Cryoviva Singapore Gets AABB Accreditation for Somatic Cells' Processing, Storage, and Distribution
Family cord blood bank Cryoviva Singapore is pleased to announce that it has now been […]
Vensica Therapeutics Closes $16 Million Investment Round
Vensica Therapeutics (“Vensica”), a clinical stage biopharmaceutical company, announced that it has closed an investment round […]
SomaLogic Announces Strategic Collaboration with University Hospitals Cleveland Medical Center to Treat Diabetic Patients at High Risk of Cardiovascular Disease
SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced a strategic collaboration with […]
Muna Therapeutics Appoints Dr. Niels Plath as Chief Scientific Officer
Muna Therapeutics (“Muna“), pioneering the development of novel, first-in-class small molecule therapeutics for neurodegenerative diseases, […]
Mindtree Launches Digital Health Passport for Travel to Improve Traveler Experience and Safety
Mindtree, a global technology services and digital transformation company, today launched Digital Health Passport for Travel, […]
Walk-in Sites Open Up For People To Get Covid-19 Booster Jab
Hundreds of walk-in sites across the country are now offering booster vaccines as the NHS […]
Amphista Therapeutics Appoints CBO, Beverley Carr
Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) approaches, today announced the […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more